Encompass Health (NYSE:EHC) EVP Sells $588,255.22 in Stock

Encompass Health Corporation (NYSE:EHC) EVP John Darby sold 4,858 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at $9,086,714.69. The trade was a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

John Patrick Darby also recently made the following trade(s):

• On Monday, August 10th, John Darby sold 8,906 shares of Encompass Health stock. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70.

Encompass Health Stock Performance

NYSE:EHC opened at $122.79 on Friday. The firm has a market capitalization of $12.11 billion, a PE ratio of 20.00, a price-to-earnings-growth ratio of 2.45 and a beta of 0.75. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The firm has a 50-day moving average price of $114.92 and a 200 day moving average price of $107.48.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.07. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Research analysts anticipate that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. The ex-dividend date is Thursday, October 1st. Encompass Health’s dividend payout ratio is currently 12.38%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on EHC shares. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. TD Cowen lifted their price target on shares of Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a report on Monday, August 10th. Truist Financial boosted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a report on Friday, May 22nd. Finally, Barclays lifted their target price on shares of Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $148.71.

Institutional Investors Weigh In On Encompass Health

A number of hedge funds have recently added to or reduced their stakes in the stock. Transamerica Financial Advisors LLC bought a new position in shares of Encompass Health in the second quarter worth about $29,000. Persistent Asset Partners Ltd acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $36,000. Keating Financial Advisory Services Inc. bought a new position in Encompass Health in the 2nd quarter worth approximately $39,000. Assetmark Inc. raised its position in Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after purchasing an additional 215 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after buying an additional 362 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.